Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines

   
   

Novel substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines, use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds, and a method of treatment employing these compounds and compositions. The compounds show a high and selective binding affinity to the histamine H3 receptor indicating histamine H3 receptor antagonistic, inverse agonistic or agonistic activity. As a result, the compounds are useful for the treatment of diseases and disorders related to the histamine H3 receptor.

 
Web www.patentalert.com

< Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene

< Tyrosine phosphatase inhibitors

> Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism

> LXR modulators

~ 00187